Lee Kalowski

Lee Kalowski

No open positions remaining

Net worth: 627 509 $ as of 2026-06-29

45 year
Health Technology
Finance
Consumer Services

Profile

Lee H.
Kalowski
is President & Chief Financial Officer at Q32 Bio, Inc. since 2024.
Formerly, Mr. Kalowski was President & Chief Financial Officer at Bicycle Therapeutics Plc from 2019 to 2023, Chief Financial Officer at Tokai Pharmaceuticals, Inc. from 2014 to 2016, Research Analyst at Sanford C.
Bernstein & Co. LLC from 2007 to 2008, Research Analyst at Prudential Equity Group LLC from 2005 to 2007, and held positions at Credit Suisse Securities (USA) LLC (Broker), Eledon Pharmaceuticals, Inc., and Bicycle Therapeutics, Inc. Education includes an undergraduate degree from Union College (New York) in 2003 and an MBA from The Wharton School of the University of Pennsylvania in 2010.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
0.29%
2026-04-14 49,255 ( 0.29% ) 627 509 $ 2026-06-29

Lee Kalowski active positions

CompaniesPositionStart

Former positions of Lee Kalowski

CompaniesPositionEnd
Director of Finance/CFO 2023-06-21
BICYCLE THERAPEUTICS PLC President 2023-06-21
Director of Finance/CFO 2016-08-30
ELEDON PHARMACEUTICALS, INC. Director of Finance/CFO 2016-07-31
Analyst-Equity -
See the detail of Lee Kalowski's experience

Training of Lee Kalowski

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

83

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Finance

Finance

Consumer Services

Finance

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology